Switzerland · Series A startup

Who invested in Inthera Biosciences

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$11Mraised across 1 round since 2017, from 1 source

Latest round
Series A, $11MMay 2017
Investors
2
See who backed them

The rounds

  1. May 2017
    Series A$11M

    Reported by FinSMEs

Everyone who backed them

Novo SeedsVC firm1round
Merck Ventures/ Aglaia BioMedicalno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Inthera Biosciences

Who invested in Inthera Biosciences?

Inthera Biosciences's investors include Novo Seeds and Merck Ventures/ Aglaia BioMedical.

How much has Inthera Biosciences raised?

Inthera Biosciences has raised $11M across 1 round since 2017.

When did Inthera Biosciences last raise?

Inthera Biosciences's most recent round was a Series A of $11M in May 2017.

What was Inthera Biosciences's biggest round?

Its most recent round, $11M in May 2017, is also its largest on record.

Who backed Inthera Biosciences first?

Inthera Biosciences's first round on record, in May 2017, was backed by Novo Seeds and Merck Ventures/ Aglaia BioMedical.

What stage is Inthera Biosciences at?

Inthera Biosciences's latest named round is a Series A, in May 2017.

Where is Inthera Biosciences based?

Inthera Biosciences is based in Switzerland.

Companies like Inthera Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.